UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
September 19, 2006
Date
of Report (Date of earliest event reported)
CONNETICS CORPORATION
(Exact name of Registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
0-27406
|
|
94-3173928 |
|
|
|
|
|
|
| (State or Other
|
|
(Commission File No.)
|
|
(IRS Employer Identification No.) |
| Jurisdiction of |
|
|
|
|
| Incorporation) |
|
|
|
|
3160 Porter Drive, Palo Alto, California 94304
(Address of principal executive offices, including zip code)
(650) 843-2800
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 8.01 Other Events.
On September 19, 2006, Connetics Corporation, or Connetics, announced that the U.S. Food and
Drug Administration (FDA) has approved Verdeso (desonide) Foam, 0.05%, for the treatment of
mild-to-moderate atopic dermatitis. Verdeso, formerly referred to as Desilux, is the first
approved product formulated in Connetics’ proprietary VersaFoam-EF emulsion formulation foam
vehicle, and first Connetics product approved for pediatric use. A copy of the Connetics press
release regarding Verdeso is attached as Exhibit 99.1 and is incorporated by reference in this Item
8.01.
Item 9.01 Financial Statements and Exhibits
| |
|
|
| Exhibit No. |
|
Description |
|
|
|
99.1
|
|
Press Release, dated September 19, 2006 regarding Verdeso Foam. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
|
|
| |
|
CONNETICS CORPORATION |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Katrina J. Church
Katrina J. Church
|
|
|
|
|
|
|
Executive Vice President, Legal Affairs |
|
|
|
|
|
|
General Counsel & Secretary |
|
|
Date: September 20, 2006